Sentinel Capital Partners Acquires TTG Imaging Solutions

"Since its founding, TTG has built a reputation of providing best-in-class services that allow physicians, imaging centers, and hospitals to offer top-quality patient care," said Paul Murphy, a Sentinel partner.

Sentinel Capital Partners, a private equity firm that invests in promising mid-market companies, today announced its acquisition of TTG Imaging Solutions, a leading national provider of nuclear medicine and molecular imaging solutions. The terms of the deal were not disclosed.

Headquartered in Pittsburgh, Pennsylvania, TTG offers end-to-end solutions for cardiology and oncology customers that use diagnostic imaging equipment. Through a nationwide network of field service engineers, TTG offers equipment, maintenance and repair services, clinical staffing, and radiopharmaceutical products. TTG operates three equipment repair centers and three radiopharmacies that serve customers across 46 states. Founded in 2004, TTG has completed nine acquisitions that have expanded its geographic coverage and added new technical capabilities.

“Since its founding, TTG has built a reputation of providing best-in-class services that allow physicians, imaging centers, and hospitals to offer top-quality patient care,” said Paul Murphy, a Sentinel partner. “The TTG team has developed an impressive growth playbook and we are thrilled to provide them the capital and support to significantly expand the business. We look forward to working with TTG’s talented team as they enter their next chapter of growth.”

“We are excited to partner with Sentinel as TTG continues to expand within the large and growing imaging services market,” said CEO Matthew Mastarone. “Our goal was to find a partner to provide capital for continuing growth over the next several years, and to support our mission of providing our customers and their patients with the highest quality of service. Sentinel is a perfect fit for what we are aiming to accomplish.”

In addition to its extensive experience in healthcare services, Sentinel has significant industry expertise in third-party equipment sales and service in a variety of end-markets. Such investments include New Era Technology (IT solutions), Mobile Communications America (networked communications), and UBEO (document management).

More

Artificial Intelligence Tools Make Education Materials More Patient Friendly

April 30, 2025

“Our study shows that widely used large language models have the potential to transform patient education materials into more readable content, which is essential for patient empowerment and better health outcomes,” said Study senior author Jonah Feldman, MD, medical director of transformation and informatics at NYU Langone.

CorWave Completes 6-Month In Vivo Study for Clinical Trials Initiation

April 24, 2025

In vivo studies demonstrated the pump’s successful operation for a period of up to six months. Additionally, nine chronic ovine implants were conducted for 60 days with no device failure or sign of thrombosis at explant. These significant milestones mark the final stage of CorWave’s preclinical development, paving the way for its First-In-Human study.